LANGHORNE, PA — Amplity Health announced that Amplity is merging with The Lynx Group. The transformational combination of Amplity and Lynx creates a differentiated scale player that offers comprehensive medical and commercial solutions to clients and the patients they serve. The Lynx Group CEO, Brian F. Tyburski, has been appointed EVP, Sales and Operations of Amplity Health and will join the Amplity Board of Directors. Amplity is a portfolio company of Altamont Capital Partners.
This is the second transaction for Amplity in less than a month after adding Middleton Access, a pricing and market access consulting firm with a leading position in Federal Access.
Michael A. Griffith, Amplity President and CEO, commented, “Medical and commercial strategies for our biopharmaceutical clients have become highly specialized, and the new entry point for commercial conversations is when clinical, medical, and specialist professionals are framing the scientific narrative and the payer/patient value proposition. Lynx engages with a unique combination of oncology and complex drug experts to create proprietary medical communications, produce topical and relevant events with their association partners, and develop high-quality scientific messages and publications that shape drug development and launch. In the past 3 years alone, Lynx has participated in 80% of all successful oncology brand launches.”
Brian Tyburski, The Lynx Group President and CEO, said, “Lynx has grown organically since our launch in 2007 while looking for the right partner to accelerate our growth and capabilities. We found that the leadership of both Amplity and Altamont share our perspectives on the future of medical and commercial solutions. Taken together, our shared vision is to build proprietary data sets and insights that inform client decisions.”
“By joining Amplity, we can globalize our content and channels, bring forward new services built on the valuable ability to access Amplity’s deep medical knowledge base, and extend our scientific content and channels to the benefit of Amplity’s customers. We will accelerate investment in new technologies to better engage our proprietary expert networks, to sharpen digital content and channels, and to expand strategic and market access consultancy services. Importantly, the combination of our capabilities allows us to bundle and manage complex services that are purchased separately today.”
Terms of the investment were not disclosed. SVB Leerink acted as financial advisor and Ropes & Gray served as legal counsel to Amplity Health in the transaction. Cain Brothers served as exclusive financial advisor and Greenberg Traurig served as legal counsel to The Lynx Group.
Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.